论文部分内容阅读
目的:探讨瘢痕子宫中期妊娠终止中采用米非司酮与依沙丫啶溶液联合治疗的临床效果。方法:将84例瘢痕子宫中期妊娠患者随机分为研究组(米非司酮+依沙丫啶溶液)与对照组(依沙丫啶溶液),对比两组治疗效果。结果:研究组引产成功率高于对照组(P<0.05);研究组宫缩时间、宫缩到娩出胎儿时间、产后出血量均优于对照组(P<0.05);研究组并发症发生率低于对照组(P<0.05)。结论:米非司酮与依沙丫啶溶液联合治疗在瘢痕子宫中期妊娠终止中效果显著,值得推广应用。
Objective: To investigate the clinical effect of mifepristone combined with ethacrynic acid solution in the termination of metaphase pregnancy of uterine scar. Methods: Eighty-four patients with uterine hypertrophy of uterus were randomly divided into study group (mifepristone + ethacridine solution) and control group (ethacridine solution). The therapeutic effect was compared between the two groups. Results: The success rate of induction of labor in the study group was higher than that of the control group (P <0.05). The time of uterine contractions, the time from uterine contractions to delivery of fetus and the amount of postpartum hemorrhage were all better than those in the control group (P <0.05). The complication rate Lower than the control group (P <0.05). Conclusion: The combination therapy of mifepristone and ethacrynic acid is effective in the termination of metaphase pregnancy of scarring uterus, which is worth popularizing and applying.